title: Opportunity, resources, and affordability: multistakeholder perspectives.
abstract: On two occasions last year, the Jefferson School of Population Health convened a National Advisory Board of scientists and opinion leaders from key stakeholder groups at a high-level forum to explore different perspectives and to discuss improving access for patients who require treatment with biologic drugs. The following is the first of two articles documenting these discussions. The second article will appear in a subsequent issue of Biotechnology Healthcare.
authors.affiliation: Janice L. Clarke, RN, BBA, Alexis Skoufalos, EdD, and David B. Nash, MD, MBA, are affiliated with the Jefferson School of Population Health, in Philadelphia. Eric Toppy is affiliated with Centocor OrthoBiotech Inc. Corresponding author: Janice L. Clarke «  janice.clarke@jefferson.edu »
authors.forename: Janice L
authors.initials: JL
authors.lastname: Clarke
authors.forename: Alexis
authors.initials: A
authors.lastname: Skoufalos
authors.forename: David B
authors.initials: DB
authors.lastname: Nash
authors.forename: Eric
authors.initials: E
authors.lastname: Toppy